Exagen (XGN) Debt to Equity (2018 - 2025)
Historic Debt to Equity for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $1.26.
- Exagen's Debt to Equity fell 1963.91% to $1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.26, marking a year-over-year decrease of 1963.91%. This contributed to the annual value of $2.12 for FY2024, which is 14703.43% up from last year.
- According to the latest figures from Q3 2025, Exagen's Debt to Equity is $1.26, which was down 1963.91% from $1.09 recorded in Q2 2025.
- Exagen's Debt to Equity's 5-year high stood at $3.27 during Q1 2025, with a 5-year trough of $0.26 in Q1 2021.
- In the last 5 years, Exagen's Debt to Equity had a median value of $0.71 in 2023 and averaged $0.93.
- Its Debt to Equity has fluctuated over the past 5 years, first crashed by 4947.54% in 2021, then surged by 23463.38% in 2025.
- Exagen's Debt to Equity (Quarter) stood at $0.32 in 2021, then soared by 110.88% to $0.68 in 2022, then grew by 25.91% to $0.86 in 2023, then skyrocketed by 147.03% to $2.12 in 2024, then plummeted by 40.4% to $1.26 in 2025.
- Its last three reported values are $1.26 in Q3 2025, $1.09 for Q2 2025, and $3.27 during Q1 2025.